Additional file 1 of CD3+T-lymphocyte infiltration is an independent prognostic factor for advanced nasopharyngeal carcinoma

Additional file 1: Supplementary Figure 1. Expression of immune-related markers in LA and MET nasopharyngeal tumors. Difference in CD3+ TIL, CD8+ TIL infiltration, subsets of TIL infiltration and Tumoral PD-L1 expression (membranous or cytoplasmic) between (A) locally advanced (LA, n = 63) versus metastatic (MET, n = 20) nasopharyngeal carcinoma cases or (B) primary tumor (1ry) and metastatic sites (MT sites) in available paired tissues from some of the LA patients before and after relapse and development of metastasis (n = 6). * Numbers indicate the median.附加文件1：补充图1。局部晚期（locally advanced, LA）与转移性（metastatic, MET）鼻咽肿瘤中的免疫相关标志物表达分析。本图展示两类对比差异：(A) 局部晚期（LA，n=63）鼻咽癌病例与转移性（MET，n=20）鼻咽癌病例之间，CD3阳性肿瘤浸润淋巴细胞（Tumor-Infiltrating Lymphocytes, TIL）、CD8阳性肿瘤浸润淋巴细胞（CD8+ TIL）的浸润水平、TIL亚群分布，以及肿瘤程序性死亡配体1（Programmed Death-Ligand 1, PD-L1）膜性或胞质表达的差异；(B) 6名局部晚期患者在复发及发生转移前后的可获取配对组织中，原发灶（primary tumor, 1ry）与转移灶（metastatic sites, MT sites）的上述指标差异。* 数值代表中位数。